Nine commercial text-to-speech systems tested on 274 medicines in clinical sentences; ElevenLabs, Google, Deepgram, Microsoft and OpenAI models drop sharply on recently approved drugs SAN FRANCISCO, Sept. 17, 2026 /PRNewswire/ -- Synthio Labs, a clinical-grade voice and agentic AI company for pharma, today published DOSE (Drug-name Oral Synthesis Evaluation), the first public benchmark of how accurately text-to-speech (TTS) systems pronounce drug names. DOSE tests nine models on 274 drug names, 146 of them newly approved, each read inside a real clinical sentence. Read the full report here.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。